ArticleSAGE open medicine2018

Amifampridine phosphate in the treatment of muscle-specific kinase myasthenia gravis: a phase IIb, randomized, double-blind, placebo-controlled, double crossover study.

Silvia Bonanno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.